TY - JOUR
T1 - JCL Roundtable
T2 - Lipid clinic operations
AU - Liebeskind, Ann
AU - Warden, Bruce A.
AU - Sikand, Geeta
AU - Duell, P. Barton
AU - Guyton, John R.
N1 - Funding Information:
Dr Liebeskind reports no disclosure or sources of funding beyond clinical practice. Dr Warden reports no disclosures or outside sources of funding. Ms. Sikand has no financial relationships to report. Dr Duell reports consultation and institutional research grants from Akcea, AstraZeneca, Esperion, Regeneron, RegenxBio, and Retrophin. Dr Guyton has received research support from Sanofi, Regeneron, and Amarin.
Funding Information:
Dr Liebeskind reports no disclosure or sources of funding beyond clinical practice. Dr Warden reports no disclosures or outside sources of funding. Ms. Sikand has no financial relationships to report. Dr Duell reports consultation and institutional research grants from Akcea, AstraZeneca, Esperion, Regeneron, RegenxBio, and Retrophin. Dr Guyton has received research support from Sanofi, Regeneron, and Amarin.
Publisher Copyright:
© 2019
PY - 2019/7/1
Y1 - 2019/7/1
N2 - Until 1990, lipid clinics in the United States existed only in academic medical centers, generally in close relationship with laboratory-based research programs. The advent of statin therapy, the success of major clinical trials to prevent or stabilize atherosclerotic cardiovascular disease, and organizational efforts highlighted by regional Lipid Disorders Training Centers and the newly formed National Lipid Association boosted the formation of lipid clinics and preventive cardiology clinics in private and academic settings. This roundtable discussion with 4 experts examines multiple aspects of lipid clinic operations: obtaining referrals, adapting to either the academic or community setting, organizing a team of providers, incorporating diet and lifestyle counseling as well as medication, establishing the pharmacist role, and gaining financial stability. Some issues are as yet unsettled, including the subspecialty home of lipidology, if any, and the diagnostic and management boundaries of practical lipid clinics. Achieving official recognition as a subspecialty has taken some steps forward but remains a challenge. Opportunities for advocacy need to be seized.
AB - Until 1990, lipid clinics in the United States existed only in academic medical centers, generally in close relationship with laboratory-based research programs. The advent of statin therapy, the success of major clinical trials to prevent or stabilize atherosclerotic cardiovascular disease, and organizational efforts highlighted by regional Lipid Disorders Training Centers and the newly formed National Lipid Association boosted the formation of lipid clinics and preventive cardiology clinics in private and academic settings. This roundtable discussion with 4 experts examines multiple aspects of lipid clinic operations: obtaining referrals, adapting to either the academic or community setting, organizing a team of providers, incorporating diet and lifestyle counseling as well as medication, establishing the pharmacist role, and gaining financial stability. Some issues are as yet unsettled, including the subspecialty home of lipidology, if any, and the diagnostic and management boundaries of practical lipid clinics. Achieving official recognition as a subspecialty has taken some steps forward but remains a challenge. Opportunities for advocacy need to be seized.
KW - Cholesterol management
KW - Lipid clinics
KW - Lipid disorders
KW - Preventive cardiology
UR - http://www.scopus.com/inward/record.url?scp=85071835819&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071835819&partnerID=8YFLogxK
U2 - 10.1016/j.jacl.2019.07.011
DO - 10.1016/j.jacl.2019.07.011
M3 - Review article
C2 - 31500839
AN - SCOPUS:85071835819
VL - 13
SP - 511
EP - 521
JO - Journal of Clinical Lipidology
JF - Journal of Clinical Lipidology
SN - 1933-2874
IS - 4
ER -